USAA
NBIX icon

United Services Automobile Association’s Neurocrine Biosciences NBIX Stock Holding History

United Services Automobile Association’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,547
Closed -$741K – 671
2025
Q1 		$741K Buy
+6,547
New +$829K 0.02% 359
2022
Q4 		– Sell
-10,443
Closed -$1.11M – 567
2022
Q3 		$1.11M Buy
10,443
+294
+3% +$29.8K 0.03% 264
2022
Q2 		$990K Buy
+10,149
New +$937K 0.03% 284
2019
Q3 		– Sell
-13,929
Closed -$1.18M – 1265
2019
Q2 		$1.18M Sell
13,929
-943
-6% -$77.4K ﹤0.01% 1257
2019
Q1 		$1.31M Sell
14,872
-588
-4% -$49.1K ﹤0.01% 1213
2018
Q4 		$1.1M Buy
15,460
+975
+7% +$93.4K ﹤0.01% 1223
2018
Q3 		$1.78M Sell
14,485
-368
-2% -$41.8K ﹤0.01% 1168
2018
Q2 		$1.46M Buy
14,853
+774
+5% +$69.3K ﹤0.01% 1232
2018
Q1 		$1.17M Buy
+14,079
New +$1.19M ﹤0.01% 1304

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

United Services Automobile Association's NBIX Position: Q2 2025 in Review

United Services Automobile Association sold out of Neurocrine Biosciences (NBIX) in Q2 2025, closing a stake of 6,547 shares — an estimated $741K sold.

United Services Automobile Association first reported a position in NBIX in Q1 2018 and held it in 9 quarters. The position peaked at $1.78M in Q3 2018. 585 funds tracked by Wall St. Rank hold NBIX as of Q2 2025.

  • United Services Automobile Association reported no remaining Neurocrine Biosciences position as of Q2 2025 after selling out during the quarter.
  • United Services Automobile Association sold 6,547 Neurocrine Biosciences shares in Q2 2025, an estimated $741K.
  • United Services Automobile Association first reported a position in Neurocrine Biosciences in Q1 2018 and held it in 9 quarters.
  • United Services Automobile Association's Neurocrine Biosciences position peaked at $1.78M in Q3 2018.
  • 585 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2025.

Based on United Services Automobile Association's 13F filing for Q2 2025, filed 15 Aug 2025.